The burgeoning interest in GLP-3 therapies for glucose control has sparked considerable investigation into their mechanisms of action, particularly concerning their potential interaction with the RET pathway. While https://arunmlsf901231.blogcudinti.com/38950945/glp-3-agonists-and-ret-signaling-a-detailed-analysis